Investing.com - Financial Markets Worldwide

Alignment Healthcare’s Joyce sells $247,950 in stock

Published 01/08/2025, 23:32
Alignment Healthcare’s Joyce sells $247,950 in stock
ALHC
5.17%

Alignment Healthcare, Inc. (NASDAQ:ALHC) Chief Legal and Admin. Officer Christopher J. Joyce, sold 15,491 shares of common stock on July 31, 2025. The shares were sold at a weighted-average price of $16.0061, resulting in a total transaction value of $247,950. The transaction occurred at a premium to the current share price of $12.97, with the stock showing strong momentum, having gained over 50% in the past year despite recent market volatility.

The price per share for the sales ranged from $16.00 to $16.01. Following the transaction, Joyce directly owns 374,531 shares of Alignment Healthcare, Inc., a company with a market capitalization of $2.56 billion and a "GOOD" financial health score according to InvestingPro analysis.

The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 27, 2024. While analysts don’t expect profitability this year, InvestingPro subscribers can access 7 additional key insights and a comprehensive Pro Research Report for deeper analysis of insider trading patterns and company fundamentals.

In other recent news, Alignment Healthcare has reported impressive financial results for the second quarter of 2025. The company achieved earnings per share (EPS) of $0.07, a significant improvement over the anticipated loss of -$0.07. Revenue for the quarter reached $1 billion, surpassing the forecasted $960.51 million, highlighting robust business growth. Additionally, the company’s EBITDA was $32 million higher than expected for its core operations, and membership growth was 1% above projections.

Barclays (LON:BARC) responded to these strong earnings by upgrading Alignment Healthcare’s stock rating from Underweight to Equalweight. The firm also raised its price target for the company to $13.00 from $9.00. These developments reflect positively on Alignment Healthcare’s recent performance and future prospects as assessed by Barclays.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.